Quest Partners LLC Has $98,000 Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Quest Partners LLC reduced its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 75.1% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 245 shares of the biotechnology company’s stock after selling 738 shares during the period. Quest Partners LLC’s holdings in Axon Enterprise were worth $98,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of the company. PFG Investments LLC lifted its stake in Axon Enterprise by 0.6% in the 3rd quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock valued at $1,547,000 after purchasing an additional 25 shares during the last quarter. Gladstone Institutional Advisory LLC lifted its stake in Axon Enterprise by 1.6% in the 3rd quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock valued at $656,000 after purchasing an additional 26 shares during the last quarter. Mather Group LLC. lifted its stake in Axon Enterprise by 3.7% in the 3rd quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock valued at $303,000 after purchasing an additional 27 shares during the last quarter. CWM LLC lifted its stake in Axon Enterprise by 1.3% in the 3rd quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock valued at $1,141,000 after purchasing an additional 36 shares during the last quarter. Finally, SPC Financial Inc. lifted its stake in Axon Enterprise by 2.2% in the 3rd quarter. SPC Financial Inc. now owns 1,773 shares of the biotechnology company’s stock valued at $708,000 after purchasing an additional 38 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total value of $12,123,000.00. Following the sale, the president now owns 208,166 shares in the company, valued at $126,179,820.90. This trade represents a 8.77 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Patrick W. Smith sold 75,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $356.53, for a total transaction of $26,739,750.00. Following the completion of the sale, the chief executive officer now owns 2,970,366 shares in the company, valued at $1,059,024,589.98. This represents a 2.46 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 210,256 shares of company stock valued at $87,783,120 over the last three months. 6.10% of the stock is owned by insiders.

Axon Enterprise Stock Up 1.9 %

Shares of AXON opened at $646.96 on Friday. Axon Enterprise, Inc. has a 12 month low of $224.28 and a 12 month high of $652.22. The firm’s 50 day moving average is $483.18 and its 200-day moving average is $376.61. The stock has a market capitalization of $49.33 billion, a PE ratio of 164.07, a P/E/G ratio of 13.97 and a beta of 0.94. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Analyst Ratings Changes

Several research firms have weighed in on AXON. JMP Securities increased their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Needham & Company LLC increased their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Robert W. Baird increased their price target on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Barclays increased their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Finally, The Goldman Sachs Group increased their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $427.83.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.